Sign up
or
Register for free
BioNation
RSS
Companies
Jobs
Drugs
News
Home
News Center
Directory
Articles
Recent
News Center
Companies
Drugs
Marketed Drugs
Investigational Drugs
Jobs
Pharma & Biotech
Chemistry
Medtech
Healthcare
Food & Beverage
Finance
Shop
Market Research
Corporate Solutions
BioFinancial News
Pipeline News
More news
BIOFINANCIAL
NEWS
Today
|
RSS
Incyte Achieves $25 Million Milestone as c-MET Inhibitor INC280 Advances Into Phase II Development
Apr 29 2013
Regado Biosciences Files for a $75 Million IPO
SCIODERM CLOSES $16 MILLION IN SERIES A FINANCING
Acumen Pharmaceuticals Inc. Announces First Closing of $20 Million Series A Financing
PIPELINE
NEWS
Today
|
RSS
CytRx Receives Recommendation from Data Safety Monitoring Committee to Complete International Phase 2b Trial with Aldoxorubicin as First-Line Treatment for Soft Tissue Sarcoma
May 6 2013
INNOVIVE PHARMACEUTICALS INC
AVEO and Astellas Report FDA Oncologic Drug Advisory Committee Votes Tivozanib Application Did Not Demonstrate Favorable Benefit-to-Risk Evaluation in Treatment of Advanced Renal Cell Carcinoma
OncoGenex Pharmaceuticals Inc. Announces Plans for the Initiation of the Rainier(TM) Clinical Trial Evaluating OGX-427 in Combination With ABRAXANE® Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer
Janssen Research and Development Release: Daratumumab Receives Breakthrough Therapy Designation in Double Refractory Multiple Myeloma From FDA
BIONATION
LOGIN
Email
Password
I've forgotten my password!
Create an account here!
CURRENT
ISSUES
Blog
